Dld Asset Management, LP Brainstorm Cell Therapeutics Inc. Transaction History
Dld Asset Management, LP
- $632 Million
- Q1 2025
A detailed history of Dld Asset Management, LP transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, Dld Asset Management, LP holds 133,700 shares of BCLI stock, worth $155,092. This represents 0.03% of its overall portfolio holdings.
Number of Shares
133,700Holding current value
$155,092% of portfolio
0.03%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BCLI
# of Institutions
5Shares Held
500KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY386KShares$448,2400.0% of portfolio
-
Raymond James & Associates St Petersburg, FL95.2KShares$110,3770.0% of portfolio
-
S.C. Financial Services, Inc.12.7KShares$14,7150.03% of portfolio
-
Institutional & Family Asset Management, LLC6KShares$6,9590.0% of portfolio
-
Piershale Financial Group, Inc.100Shares$1150.0% of portfolio
About BRAINSTORM CELL THERAPEUTICS INC.
- Ticker BCLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,486,200
- Market Cap $42.3M
- Description
- Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...